← SynDRA
FGF401
SynDRA canonical compound SYN0038627 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | FGFR4 |
| Mechanism of action | FGFR inhibitor |
All known targets
Mechanisms of action (all sources)
- FGFR4 INHIBITOR
- Fibroblast growth factor receptor 4 inhibitor
- FGFR inhibitor
- FGFR4 ANTAGONIST
Cross-references
Synonyms
- ROBLITINIB
- CPD84
- FGF
- FGF-401
- ROBLITINIB (FGF401)
- Roblitinib
- UNII-M64JF6WMSA
- M64JF6WMSA
- N-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-7-formyl-6-[(4-methyl-2-oxopiperazin-1-yl)methyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
- N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
- Roblitinib [INN]
- NVP-FGF401
- GTPL9768
- FGF 401 [WHO-DD]
- CHEMBL3908979
- SCHEMBL16668840
- BHKDKKZMPODMIQ-UHFFFAOYSA-N
- MolPort-044-756-212
- BDBM209325
- EX-A1341
- FGF 401
- roblitinibum
- RefChem:179727
- FGFR4 Inhibitor FGF401
- Roblitinib (FGF401)
- C25H30N8O4
- Roblitinib; FGF-401
- FGF401( Roblitinib)?
- ROBLITINIB [WHO-DD]
- NVP-FGF-401
- orb1303035
- SCHEMBL29356752
- GLXC-10719
- Example 83 [US9266883]
- NSC804962
- s8548
- AKOS032946374
- CCG-269749
Look up FGF401 in the interactive SynDRA portal →